Enzyme Role Found for Aging Gene

Graphic: Courtesy of Shin-Ichiro Imai  SILENCE OF THE CHROMATIN: The Sir2 protein requires NAD for its enzymatic activity. It couples NAD breakdown to nicotinamide and ADP-ribose with the removal of acetyl groups from histone and other proteins. The acetyl moiety is transferred to ADP-ribose, which creates the chemical acetyl-ADP ribose. Deacetylated nucleosome are packed up to silenced chromatin structure and involved in silencing gene transcription. This Sir2 enzymatic activity links ene

Written byJennifer Fisher Wilson
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Some twenty years ago, Massachusetts Institute of Technology biologist Lenny Guarente began studying aging by timing the lifespan of various yeast strains. Finding one mutant strain that lived about 50% longer than the others, Guarente's team searched the mutant's genome to uncover its secret to long life. The investigation singled out a silent information regulator gene called Sir2, which was expressed at a higher-than-normal rate.

Learning just how Sir2 functions to extend life became Guarente's goal. Only after years of confusing results did he and then-postdoc Shin-ichiro Imai, in a dramatic "Aha!" moment, finally figure it out. Sir2 is not an ADP-ribosylating enzyme--an enzyme that adds ADP ribose to a protein, as some studies had suggested and which they had been trying to prove--but rather, it is a histone deacetylase, an enzyme that removes a small part of a protein (an acetyl group) around which DNA is wound. Furthermore, as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies